Hwail Pharmaceutical Co.Ltd Long-term Investment Intensity
Hwail Pharmaceutical Co.Ltd long-term investment intensity. Hwail Pharmaceutical Co.Ltd (061250) has a Long-term Investment Intensity of 6.1% as of March 2017. Long-term investments of ₩7.77 Billion represent 6.1% of total assets of ₩127.96 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Hwail Pharmaceutical Co.Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Hwail Pharmaceutical Co.Ltd (2013–2016)
Long-term investment intensity of Hwail Pharmaceutical Co.Ltd from 2013 to 2016. This chart shows how Hwail Pharmaceutical Co.Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2013 to 2016. As of March 2017, the intensity stands at 6.1%, reflecting long-term investments of ₩7.77 Billion against total assets of ₩127.96 Billion KRW.
Hwail Pharmaceutical Co.Ltd Long-term Investment Intensity by Year (2013–2016)
Hwail Pharmaceutical Co.Ltd long-term investment intensity by year from 2013 to 2016. The table below presents the year-by-year Long-term Investment Intensity for Hwail Pharmaceutical Co.Ltd from 2013 to 2016, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Hwail Pharmaceutical Co.Ltd (061250) total assets.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2016 | 6.8% | ₩8.78 Billion | ₩128.62 Billion | ▼ -2.4 pp |
| 2015 | 9.2% | ₩12.96 Billion | ₩140.27 Billion | ▲ +8.3 pp |
| 2014 | 1.0% | ₩1.18 Billion | ₩122.92 Billion | ▼ -1.7 pp |
| 2013 | 2.6% | ₩3.23 Billion | ₩123.02 Billion | — |